{
  "docId": "019de518-6502-70bc-9a44-c6a9c7f323b5",
  "docSlug": "4230ce80abe7092521a593effe59cbcd",
  "documentTitle": "Oculis | Investor Presentation Deck | 48 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 48,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de518-6502-70bc-9a44-c6a9c7f323b5/13",
  "deckHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5",
  "deckJsonHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5.json",
  "deckAnchorHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.046,
        "w": 0.239,
        "x": 0.729,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis Diamond",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "edfee37f-ec4a-4483-b571-c9ba53c35f5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.95,
        "x": 0.025,
        "y": 0.18
      },
      "kind": "list",
      "text": "7.2-letter gain in BCVA vs baseline at week 6, increasing to 7.6 at week 12",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "121d2c64-65df-45c9-acf5-9508ee189802",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.95,
        "x": 0.025,
        "y": 0.43
      },
      "kind": "list",
      "text": "Rapid reduction in retinal edema already at week 2",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "18a40585-c3ad-4948-b615-2cb3e62cb04c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.95,
        "x": 0.025,
        "y": 0.555
      },
      "kind": "list",
      "text": "Well-tolerated with no unexpected AEs",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "335b6575-184b-4ffb-8287-da7e242bd1a4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.95,
        "x": 0.025,
        "y": 0.305
      },
      "kind": "list",
      "text": "25.3% of patients gained ≥15 letters at week 6, increasing to 27.4% at week 12",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63b8f851-06ec-4c5a-994a-5e3a5f8215cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.105,
        "w": 0.95,
        "x": 0.025,
        "y": 0.68
      },
      "kind": "list",
      "text": "Results supported Stage 2 initiation",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c3d7e92-1de5-4bbc-8ef4-4e81a6677f52",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.33,
        "x": 0.025,
        "y": 0.915
      },
      "kind": "source-note",
      "text": "AE (Adverse event); BCVA (Best corrected visual acuity).",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19bee190-40c6-419e-9f56-c5434b55d4dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.95,
        "x": 0.025,
        "y": 0.092
      },
      "kind": "title",
      "text": "Robust statistically significant improvement in vision and reduction in retinal edema vs vehicle",
      "attrs": {},
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e4c91de-139f-4942-8135-0aee76fcf2a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.046,
        "w": 0.63,
        "x": 0.025,
        "y": 0.046
      },
      "kind": "title",
      "text": "5 Key Takeaways From OCS-01 DIAMOND Stage 1",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3da1909-8882-4b70-9b47-26de9334404f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}